OSX Shares Osteopore Limited
ASX · ASXLast in our picks 2026-10-26 — not in the current list; analysis below is from that screen
3D-printed regenerative implants offer differentiated technology exposure with commercialization upside.
Signal breakdown
- ▸Commercial execution and hospital adoption remain key catalysts.
- ▾Below 50-day MA (-0.25%)
- ▾Near 52-week low (3.8% of range)
Is OSX a buy right now?
Trend: OSX is trading RSI 32 — neutral momentum, with a 3-month return of +0.00%.
Valuation & quality: fundamentals show net margin -135.8%, revenue growth -8.4% year on year.
Our screen: WATCH (score 0) — 3D-printed regenerative implants offer differentiated technology exposure with commercialization upside.
Computed from end-of-day data; not personal advice.
12-month price chart
Monthly returns
| Mar 26 | Apr 26 | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|---|---|
| +0.00% | +0.00% | +0.00% | -100.00% | — | — | — | — |
Fundamentals
Technical signals
About Osteopore Limited
Osteopore Limited, a regenerative medicine company, engages in the production of 3D-printed biomimetic and bioresorbable implants in Vietnam, South Korea, the Philippines, Singapore, India, Taiwan, Indonesia, the Netherlands, the United Arab Emirates, Australia, and internationally.
Sector: Healthcare · Industry: Medical Instruments & Supplies · Singapore · Website
Related Biotech picks
Browse: all ASX stocks · Biotech picks · today's movers
Market data from end-of-day feeds; AI-generated research for educational purposes only — not investment advice.